Member-only story
Life Through The Nose: FDA Approves Nasal Spray Narcan
A nasal spray version of the standard opioid overdose treatment Narcan for OTC and nonprescription use has been approved by the FDA.
A little bit of pharmacological cavalry is coming for first responders and others who are on the front lines of the overdoes tsunami that claimed over 100k lives in fiscal year 2022 in America. A nasal spray version of the standard opioid overdose treatment Narcan, naloxone hydrochloride, in over-the-counter and nonprescription form has been approved by the FDA.
Today, the U.S. Food and Drug Administration approved Narcan, 4 milligram (mg) naloxone hydrochloride nasal spray for over-the-counter (OTC), nonprescription, use — the first naloxone product approved for use without a prescription. Naloxone is a medication that rapidly reverses the effects of opioid overdose and is the standard treatment for opioid overdose. Today’s action paves the way for the life-saving medication to reverse an opioid overdose to be sold directly to consumers in places like drug stores, convenience stores, grocery stores and gas stations, as well as online.
The timeline for availability and price of this OTC product is determined by the manufacturer. The FDA will work with all stakeholders to help…
